Expression and localization of transcription factor Ets-1 in the rat ovary during the estrous cycle and pregnancy

Fertility and Sterility

Volumn 91, Issue 5 SUPPL., 2009, Pages 1998-2005

  Xiao, Xiaohui ^a   Liu, Aiqin ^a   Wen, Haixia ^a   Tian, Yanjun ^a   Ni, Jiang ^a   Liu, Guoyi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

corpus luteum; estrous cycle; Ets 1; follicle; pregnancy; rat

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR ETS 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; ESTRUS CYCLE; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METESTRUS; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROESTRUS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ANIMALS; CORPUS LUTEUM; DNA, COMPLEMENTARY; ESTRUS; FEMALE; IN SITU HYBRIDIZATION; OVARIAN FOLLICLE; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY, ANIMAL; PROTO-ONCOGENE PROTEIN C-ETS-1; RATS; RATS, WISTAR; RNA; RNA, MESSENGER;

EID: 65049090125     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.02.166     Document Type: Article

References (44)

1. Wasylyk B., Hahn S.L., and Giovane A. The Ets family of transcription factors. Eur J Biochem 211 (1993) 7-18
2. Nunn M.F., Seeburg P.H., Moscovici C., and Duesberg P.H. Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 306 (1983) 391-395
3. Lelievre E., Lionneton F., Soncin F., and Vandenbunder B. The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int J Biochem Cell Biol 33 (2001) 391-407
4. Gilliland D.G. The diverse role of the ETS family of transcription factors in cancer. Clin Cancer Res 7 (2001) 451-453
5. Koskela K., and Lassila O. Single-cell analysis of Ets-1 transcription factor expression during lymphocyte activation and apoptosis. Scand J Immunol 57 (2003) 56-61
6. Marziali G., Perrotti E., Ilari R., Lulli V., Coccia E.M., Moret R., et al. Role of Ets-1 in transcriptional regulation of transferrin receptor and erythroid differentiation. Oncogene 21 (2002) 7933-7944
7. Ozaki I., Zhao G., Mizuta T., Ogawa Y., Hara T., Kajihara S., et al. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol 36 (2002) 169-178
8. Lincoln II D.W., Phillips P.G., and Bove K. Estrogen-induced Ets-1 promotes capillary formation in an in vitro tumor angiogenesis model. Breast Cancer Res Treat 78 (2003) 167-178
9. Raouf A., and Seth A. Ets transcription factors and targets in osteogenesis. Oncogene 19 (2000) 6455-6463
10. Maroulakou I.G., and Bowe D.B. Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene 19 (2000) 6432-6442
11. Gutman A., and Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding site. EMBO J 9 (1990) 2241-2246
12. Wasylyk C., Gutman A., Nicholson R., and Wasylyk B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 10 (1991) 1127-1134
13. Gum R., Lengyel E., Juarez J., Chen J.H., Sato H., Seiki M., et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271 (1996) 10672-10680
14. Nerlov C., De Cesare D., Pergosa F., Caracciolo A., Blasi F., Johnsen M., et al. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J 11 (1992) 4573-4582
15. Logan S.K., Garabedian M.J., Campbell C.E., and Werb Z. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J Biol Chem 271 (1996) 774-782
16. Iwasaka C., Tanaka K., Abe M., and Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 169 (1996) 522-531
17. Elvert G., Kappel A., Heidenreich R., Englmeier U., Lanz S., Acker T., et al. Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 278 (2003) 7520-7530
18. Quintana R., Kopcow L., Sueldo C., Marconi G., Rueda N.G., and Baranao R.I. Direct injection of vascular endothelial growth factor into the ovary of mice promotes follicular development. Fertil Steril 82 (2004) 1101-1105
19. Shimizu T., Jayawardana B.C., Tetsuka M., and Miyamoto A. Differential effect of follicle-stimulating hormone and estradiol on expression of vascular endothelial growth factor (VEGF)120, VEGF164 and their receptors in bovine granulosa cells. J Reprod Dev 53 (2007) 105-112
20. Juengel J.L., and McNatty K.P. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum Reprod Update 11 (2005) 143-160
21. Goldman S., and Shalev E. The role of the matrix metalloproteinases in human endometrial and ovarian cycles. Eur J Obstet Gynecol Reprod Biol 111 (2003) 109-121
22. Liu Y.X. Plasminogen activator/plasminogen activator inhibitors in ovarian physiology. Front Biosci 9 (2004) 3356-3373
23. Fujimoto J., Aoki I., Toyoki H., Khatun S., Sato E., and Tamaya T. Expression of ETS-1 related to angiogenesis in uterine endometrium during the menstrual cycle. J Biomed Sci 10 (2003) 320-327
24. Davidson B., Goldberg I., Gotlieb W.H., Kopolovic J., Risberg B., Ben-Baruch G., et al. Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?. Cancer Metastasis Rev 22 (2003) 103-115
25. Liu G.Y., Lin H.Y., Zhang X., Li Q.L., Wang H.M., Qian D., et al. Expression of Smad2 and Smad4 in mouse uterus during the oestrous cycle and early pregnancy. Placenta 25 (2004) 530-537
26. Ito M., Nakayama T., Naito S., Matsuu M., Shichijo K., and Sekine I. Expression of Ets-1 transcription factor in relation to angiogenesis in the healing process of gastric ulcer. Biochem Biophys Res Commun 246 (1998) 123-127
27. Kola I., Brookes S., Green A.R., Garber R., Tymms M., Papas T.S., et al. The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci U S A 90 (1993) 7588-7592
28. Tomita N., Morishita R., Taniyama Y., Koike H., Aoki M., Shimizu H., et al. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 107 (2003) 1411-1417
29. Pourtier-Manzanedo A., Vercamer C., Van Belle E., Mattot V., Mouquet F., and Vandenbunder B. Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model. Oncogene 22 (2003) 1795-1806
30. Span P.N., Manders P., Heuvel J.J., Thomas C.M., Bosch R.R., Beex L.V., et al. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene 21 (2002) 8506-8509
31. Oettgen P. Regulation of vascular inflammation and remodeling by ETS factors. Circ Res 99 (2006) 1159-1166
32. Gallant S., and Gilkeson G. ETS transcription factors and regulation of immunity. Arch Immunol Ther Exp (Warsz) 54 (2006) 149-163
33. Kilpatrick L.M., Kola I., and Salamonsen L.A. Transcription factors Ets1, Ets2, and Elf1 exhibit differential localization in human endometrium across the menstrual cycle and alternate isoforms in cultured endometrial cells. Biol Reprod 61 (1999) 120-126
34. Koo T.B., Song H., Moon I., Han K., Chen C., Murphy K., et al. Differential expression of the PEA3 subfamily of ETS transcription factors in the mouse ovary and peri-implantation uterus. Reproduction 129 (2005) 651-657
35. Stocco C., Telleria C., and Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr Rev 28 (2007) 117-149
36. Quirk S.M., Cowan R.G., Harman R.M., Hu C.L., and Porter D.A. Ovarian follicular growth and atresia: the relationship between cell proliferation and survival. J Anim Sci 82 (2004) E40-E52
37. Jiang J.Y., Cheung C.K., Wang Y., and Tsang B.K. Regulation of cell death and cell survival gene expression during ovarian follicular development and atresia. Front Biosci 8 (2003) d222-d237
38. Behl R., and Kaul R. Insulin like growth factor 1 and regulation of ovarian function in mammals. Indian J Exp Biol 40 (2002) 25-30
39. Hazzard T.M., and Stouffer R.L. Angiogenesis in ovarian follicular and luteal development. Baillieres Best Pract Res Clin Obstet Gynaecol 14 (2000) 883-900
40. Murphy B.D., Gevry N., Ruiz-Cortes T., Cote F., Downey B.R., and Sirois J. Formation and early development of the corpus luteum in pigs. Reprod Suppl 58 (2001) 47-63
41. Fraser H.M., and Wulff C. Angiogenesis in the corpus luteum. Reprod Biol Endocrinol 1 (2003) 88
42. Chang J., Lee C., Hahm K.B., Yi Y., Choi S.G., and Kim S.J. Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells. Oncogene 19 (2000) 151-154
43. Lincoln II D.W., and Bove K. The transcription factor Ets-1 in breast cancer. Front Biosci 10 (2005) 506-511
44. Bradford A.P., Brodsky K.S., Diamond S.E., Kuhn L.C., Liu Y., and Gutierrez-Hartmann A. The Pit-1 homeodomain and beta-domain interact with Ets-1 and modulate synergistic activation of the rat prolactin promoter. J Biol Chem 275 (2000) 3100-3106